|
#1
26.11.2014, 02:23
|
||||
|
||||
|
Çàíèìàòåëüíî î ôåêàëüíîé òðàíñïëàíòàöèè
Òðàíñïëàíòàöèÿ ôåêàëüíîé ìèêðîáèîòû
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] èç íåäàâíèõ ïóáëèêàöèé: Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. Youngster I, Russell GH, Pindar C, Ziv-Baran T, Sauk J, Hohmann EL. JAMA. 2014 Nov 5;312(17):1772-8. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] èëè îáçîð ñ ìåòà- àíàëèçîì J Crohns Colitis. 2014 Sep 12. Fecal microbiota transplantation as therapy for inflammatory bowel disease: A systematic review and meta-analysis. Colman RJ, Rubin DT. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] 
|
|
#2
26.11.2014, 21:10
|
||||
|
||||
|
Ñìåõ-ñìåõîì, íî êîãäà ïñåâäîìåìáðàíîçíûé êîëèò íå îòâå÷àåò íà ëå÷åíèå âàíêîìèöèíîì è ìåòðîíèäàçîëîì - îá ýòîì òîæå íàäî ïîìíèòü.
|
|
#3
26.11.2014, 22:06
|
||||
|
||||
|
Îá óñïåøíîì èçëå÷åíèè òàêèì ìåòîäîì ñ îäíîãî ðàçà ðåôðàêòåðíîãî êîëèòà, îáóñëîâëåííîãî Clostridium difficile, íàãëÿäíî (â êàðòèíêàõ) ïèøóò íåìöû âîò â ýòîì ïîëíîòåêñòå:
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] ïåðâîíà÷àëüíîå ëå÷åíèå - ìåòðîíèäàçîë, çàòåì âàíêîìèöèí, çàòåì Nitazoxanide - ïàóçà - ðåöèäèâ - Nitazoxanide, Nitazoxanide + Rifaximin, Rifaximin - ðåìèññèÿ - âòîðîé ðåöèäèâ - Tigecyclin, FMT - ïîëãîäà â ðåìèññèè è íåò ðåöèäèâà.
|
|
#4
01.12.2014, 23:50
|
||||
|
||||
|
Ôàêò äàâíî èçâåñòíûé. Íî êàê â ôèëüìå Ðîãîæêèíà "Îñîáåííîñòè íàöèîíàëüíîé îõîòû". Ïîìíèòå ñþæåò ñ êîðîâîé â áîìáîâîì îòñåêå áîìáàðäèðîâùèêà? "Æèòü çàõî÷åøü - íå òàê ðàñêàðÿ÷èøüñÿ"? òàê è ñ ýòèìè ïàöèåíòàìè - òÿæåëûìè. Åñëè íè÷åãî íå ïîìîãàåò è ïàöèåíò "ñòðåìíûé" - íà ôåêàëüíóþ òðàíñïëàíòàöèþ ïîéäåøü!!!
|
|
#5
12.10.2015, 21:55
|
||||
|
||||
|
Îêàçûâàåòñÿ, äîíîðîâ ïîðÿäî÷íûõ ôåêàëèé íàéòè íå òàê óæ è ïðîñòî:
In total, only 12 of 116 (10%) potential donors were enrolled as study donors... Recruitment of fecal donors for FMT is challenging with only a small percentage ultimately serving as donors... A surprisingly large proportion of healthy asymptomatic donors failed stool testing, primarily due to gastrointestinal parasites. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
|
|
#6
11.07.2017, 18:21
|
|||
|
|||
|
Íîâûå äàííûå ïî ýòîé òåìå-
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Ó íàñ â Íîâîñèáèðñêå , ýòî äåëàþò. Ðåçóëüòàòû , íå çíàþ..
|
|
#7
11.07.2017, 18:32
|
||||
|
||||
|
Åñëè ãîâîðèòü óæ î íîâèíêàõ â ýòîé òåìå, òî èç íåîáû÷íîãî íåäàâíåãî:
Fecal microbiota transplantation cured epilepsy in a case with Crohn's disease: The first report. He Z, Cui BT, Zhang T, Li P, Long CY, Ji GZ, Zhang FM. World J Gastroenterol. 2017 May 21;23(19):3565-3568. Fecal microbiota transplantation in metabolic syndrome: History, present and future. de Groot PF, Frissen MN, de Clercq NC, Nieuwdorp M. Gut Microbes. 2017 May 4;8(3):253-267. Can fecal microbiota transplantation cure irritable bowel syndrome? Halkjær SI, Boolsen AW, Günther S, Christensen AH, Petersen AM. World J Gastroenterol. 2017 Jun 14;23(22):4112-4120. ïîëíûé òåêñò åâðîêîíñåíñóñà 2017 European consensus conference on faecal microbiota transplantation in clinical practice [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
|
|
#8
30.11.2017, 20:44
|
||||
|
||||
|
Öèòàòà:
Îíà ñ ñî÷åòàííûì äèàãíîçîì: ïåðåíåñëà êëîñòðèäèàëüíûé êîëèò, óñïåøíî ïðîëå÷åííûé ìåòðîíèäàçîëîì + ëàêòàçíàÿ íåäîñòàòî÷íîñòü + ÑÐÊ.  èòîãå- âåëèêîëåïíûé ýôôåêò íà àìèòðèïòèëèíå ñ ëîïåðàìèäîì ))
|
Ëèíåéíûé âèä
